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INTRODUCTION 
 
Nanotechnology is a revolution in applied science. By manipulating molecules on 
the scale of billionths-of-a-meter, scientists have created materials that exhibit “almost 
magical feats of conductivity, reactivity, and optical sensitivity, among others.”1 
Nanotechnology also has the potential to drive an economic revolution. Retailers 
already sell over 300 products that incorporate nanotechnology,2 and according to one 
estimate, nanotechnology will be a trillion-dollar-a-year industry by 2015.3 In 
congressional testimony, Ray Kurzweil, Chairman and Chief Executive Officer of 
Kurzweil Techonologies, asserted that nanotechnology would result in the pervasive 
miniaturization of all human industry by the middle of the twenty-first century.4
The tremendous economic benefit of nanotechnology, however, will come at a 
price. Nanotechnology applications present novel, serious, and possibly irreversible 
threats to human health and the environment. Recently, the field of nanotoxicology has 
been developed to characterize and quantify these threats.
 Part I 
of this Article describes the emerging field of nanotechnology and its applications. 
5
Because of nanotechnology’s mixed blessing, the United States government must 
select a strategy to maximize nanotechnology’s economic potential while containing its 
health and environmental dangers. Part III of this Article argues that the best strategy is 
to incorporate nanotechnology regulation into a general-purpose toxic substances 
statute, such as by amending the Toxic Substances Control Act (TSCA), which is 
intended to regulate all chemical substances at the point of manufacture.
 Part II of this Article 
discusses the early research demonstrating health and environmental dangers 
associated with nanotechnology.  
6
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Part IV of this Article provides background on toxic substances law, and Part V 
proposes changes to United States toxic substances law to address nanotechnology’s 
threat. Two laws figure heavily into this discussion: TSCA and the European Union 
directive, known as Registration, Evaluation, and Authorisation of Chemicals 
(REACH).7 REACH is modeled to a large degree on TSCA, but addresses many of 
TSCA’s perceived shortcomings. Congress is considering revising TSCA based on 
REACH, which would essentially create a third-generation toxic substances statute.8
I. NANOTECHNOLOGY IS A HETEROGENEOUS GROUP OF TECHNOLOGIES 
 
Part V explains that proposed amendments to TSCA based on REACH do an 
incomplete job of addressing the threats posed by nanotechnology and makes 
suggestions.  
The United States Environmental Protection Agency (EPA) defines nanotechnology 
as:  
research and technology development at the atomic, molecular, or macromolecular 
levels using a length scale of approximately one to one hundred nanometers [i.e., 
billionths of a meter] in any dimension; the creation and use of structures, devices 
and systems that have novel properties and functions because of their small size; 
and the ability to control or manipulate matter on an atomic scale.9
This definition covers both nanomaterials, which are materials with at least one 
dimension on a scale of nanometers, and nanotechnology processes, which describes 
the direct manipulation of atoms, molecules, or nanomaterials for human purposes.
  
10
Because the EPA’s definition is so broad, the reader may find some concrete 
examples of nanotechnology to be helpful. In 2007, the EPA Nanotechnology White 
Paper described four existing categories of nanotechnology (all of which are 
nanomaterials): 
  
 
                                                                                                                 
 
 7. Council Regulation No. 1907/2006, Registration, Evaluation, and Authorisation of 
Chemicals (REACH) (EC), available at http://eurlex.europa.eu/LexUriServ/LexUriServ.do 
?uri=CELEX:32006R1907:EN:NOT. 
 8. See infra Part IV.C. 
 9. SCI. POLICY COUNCIL, supra note 2, at 5. Glenn Harlan Reynolds defines 
nanotechnology as “the science and technology of building from the bottom up—one atom or 
molecule at a time.” Glenn Harlan Reynolds, Nanotechnology and Regulatory Policy: Three 
Futures, 17 HARV. J.L. & TECH. 179, 181 (2003). Scott Segal has described nanotechnology as 
being comprised of machines less than 100 nanometers in size. Scott H. Segal, Environmental 
Regulation of Nanotechnology: Avoiding Big Mistakes for Small Machines, 1 
NANOTECHNOLOGY L. & BUS. 290, 291 (2004). Other commentators describe nanotechnology as 
a “heterogeneous family of technologies” without much further elaboration. E.g., Diana M. 
Bowman & Graeme A. Hodge, A Small Matter of Regulation: An International Review of 
Nanotechnology Regulation, 8 COLUM. SCI. & TECH. L. REV. 1, 2 (2007). 
 10. See Nakissa Sadrieh & Parvaneh Espandiari, Nanotechnology and the FDA: What Are 
the Scientific and Regulatory Considerations for Products Containing Nanomaterials?, 3 
NANOTECHNOLOGY L. & BUS. 339, 342 (2006) (distinguishing nanomaterials and 
nanotechnology processes). 
26 INDIANA LAW JOURNAL SUPPLEMENT [Vol. 85:24 
 
1. Carbon-based materials including “hollow spheres, ellipsoids, and 
tubes.”11 Carbon nanotubes can have enormous tensile strength 
and have been used to reinforce building materials.12 Recently, 
scientists created a carbon nanotube structure that absorbed almost 
all visible light, making it the world’s “blackest” material.13 The 
optical properties of nanotubes show promise in solar cell 
applications.14
 
 
2. Metal-based materials including quantum dots, which are tiny, 
closely-packed semiconductor crystals.15 They show promise for 
use as “qubits” for quantum information processing in the next 
generation of computers.16
 
  
3. Dendrimers, which are tiny, branched structures.17 They show 
promise as vectors for drug delivery. Recently, scientists have 
developed “nanobees” which deliver melittin, a toxin present in 
bee stings, directly to cancer cells within the human body.18
 
 
4. Composites of nanomaterials and conventional materials. By 
embedding nanotechnology in materials, researchers create new 
materials with enhanced physical or chemical properties.19 One 
field involving composites is “nanobiotechnology,” which involves 
combining nanomaterials with naturally occurring molecules, 
including DNA.20 These composites may be useful in treating 
disease through somatic gene therapy.21
 
 
The EPA predicts that scientists will rapidly create new categories of 
nanotechnologies. Future nanotechnology applications may include the following: 
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examples/QM/loss_pra_57_120_98.pdf. 
 17. SCI. POLICY COUNCIL, supra note 2, at 9. 
 18. Tumors Feel the Deadly Sting of Nanobees, SCI. DAILY, Aug. 10, 2009, 
http://www.sciencedaily.com/releases/2009/08/090810174226.htm. 
 19. SCI. POLICY COUNCIL, supra note 2, at 10.  
 20. Kevin Rollins, Nanobiotechnology Regulation: A Proposal for Self-Regulation with 
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1. Molecular assemblers. A molecular assembler is a device used to 
assemble bulk-scale materials molecule-by-molecule (that is, through 
a nanotechnology process).22 In the future, molecular assembly may 
allow the assembly of large goods such as cars, airplanes and 
buildings molecule-by-molecule and without the assistance of human 
workers.23
 
 
2. Nanorobotics. Researchers are attempting to engineer robots on a 
nanometer scale.24 These robots may be useful in performing surgery 
within the human body.25
 
  
3. Imaging technologies. Nanotechnology may lead to the next 
generation of television. Researchers are currently attempting to 
create holograms by manipulating molecules in the gas phase.26
II. THE HEALTH AND ENVIRONMENTAL DANGERS OF NANOTECHNOLOGY 
 
“Nanotoxicology” is defined as the “science of engineered nanodevices and 
nanostructures that deals with their effects in living organisms.”27 Because 
nanotoxicology is a new field, detailed heath and safety data for many nanotechnology 
applications is nonexistent.28
First, because of their small size, nanotechnology applications can pass through the 
protective membranes of the human body, including the cell membranes of the skin, 
gastrointestinal tract, and lungs.
 However, existing nanotoxicology research suggests at 
least three themes that tend to make nanotechnology applications more dangerous than 
ordinary materials.  
29 Nanomaterials have even been shown to cross the 
blood/brain barrier in rats, which is regarded as the body’s tightest junction.30 Once 
nanomaterials penetrate the body’s outer defenses, they can migrate to the blood stream 
or lymph system, circulate throughout the human body, and deposit in organs, tissues, 
and cells, where they bioaccumulate.31
Second, nanotechnology applications have higher chemical activity than ordinary 
materials. This higher activity is due to the fact that small objects (such as 
  
                                                                                                                 
 
 22. See Reynolds, supra note 9, at 185. 
 23. See id. at 186. 
 24. See SCI. POLICY COUNCIL, supra note 2, at 12. 
 25. Oberdörster et al., supra note 5, at 824 (discussing the use of nanorobots for targeted 
drug delivery). 
 26. Christopher R. Moon, Lalia S. Mattos, Brian K. Foster, Gabriel Zeltzer & Hari C. 
Manoharan, Quantum Holographic Encoding in a Two-Dimensional Electron Gas, 4 NATURE 
NANOTECHNOLOGY 167 (2009). 
 27. Oberdörster et al., supra note 5, at 824. 
 28. See, e.g., id. at 828. 
 29. Id. at 829–35 (summarizing research on how nanoparticles infiltrate and circulate 
through the body). 
 30. G. Oberdörster, Z. Sharp, V. Atudorei, A. Elder, R. Gelein, W. Kreyling & C. Cox, 
Translocation of Inhaled Ultrafine Particles to the Brain, 16 INHALATION TOXICOLOGY 437, 441 
(2004) (showing translocation of nanoparticles into the brains of rats). 
 31. Oberdörster et al., supra note 5, at 829. 
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nanomaterials) have much higher surface area per unit volume than large objects (such 
as conventional materials).32 Because chemical reactions usually occur at exposed 
surfaces, nanomaterials are much more chemically reactive, and thus more toxic, than 
ordinary materials.33 For example, as a result of its high surface area, inhaled nanoscale 
titanium dioxide, which is used in sunscreens, has been shown to generate a greater 
inflammatory response than ordinary titanium dioxide.34
 Third, nanotechnology applications behave in unpredictable (even “magical”) ways 
because the laws of quantum mechanics, as opposed to Newtonian physics, become 
increasingly important with diminishing size.
 
35 As a result, nanomaterials are toxic by 
different mechanisms than their bulk-scale counterparts. For example, a study found 
that nanoscale iron oxide was extremely toxic by an unknown mechanism.36
Future nanotechnology applications also will present other dangers. Currently, 
toxicological data only exists for “first generation” nanotechnology applications, which 
generally consist of small particles.
 In 
summary, nanomaterials may infiltrate the body in higher-than-expected numbers, 
reach unexpected parts of the body, bioaccumulate throughout the body, be more toxic 
than expected, and cause toxic effects of a completely different character than those 
associated with ordinary substances of the same chemical identity. 
37 The EPA predicts that by 2015 it may be possible 
to design nanosized robots.38 Eric Drexler has expressed concern that uncontrolled 
self-replication of nanorobots could result in uncontrolled molecular nanotechnology 
chewing the world down to “grey goo.”39
III. THE CASE FOR AMENDING TSCA TO REGULATE NANOTECHNOLOGY 
 Of course, no one knows if this could 
actually happen. However, the “grey goo” hypothetical does illustrate that higher-
generation nanotechnologies will present novel risks. 
Several commentators have argued that Congress should pass a nanotechnology-
specific law.40
                                                                                                                 
 
 32. Id. at 825 tbl.2 (illustrating the relationship between diameter and surface area). 
 This Part argues that nanotechnology should be regulated under a 
general-purpose toxic substances law, such as TSCA, for two reasons: first, because the 
subject matter of a “nanotechnology” statute may be difficult or impossible to define; 
 33. Id. at 823. 
 34. Id. at 826. 
 35. See SCI. POLICY COUNCIL, supra note 2, at 13. 
 36. Tobias J. Brunner, Peter Wick, Pius Manser, Philipp Spohn, Robert N. Grass, Ludwig 
K. Limbach, Arie Bruinink & Wendelin J. Stark, In Vitro Cytotoxicity of Oxide Nanoparticles: 
Comparison to Asbestos, Silica, and the Effect of Particle Solubility, 40 ENVTL. SCI. & TECH. 
4374, 4379 (2006). 
 37. See SCI. POLICY COUNCIL, supra note 2, at 12–13 (explaining the need for the EPA to 
have the flexibility to adjust to changing generations of nanotechnology). 
 38. Id. at 13. 
 39. K. ERIC DREXLER, ENGINES OF CREATION 171–90 (1986). 
 40. See, e.g., J. CLARENCE DAVIES, MANAGING THE EFFECTS OF NANOTECHNOLOGY 10 
(2006), available at http://www.wilsoncenter.org/index.cfm?fuseaction=news.item&news_id= 
165552 (proposing a nanotechnology-specific law); Albert C. Lin, Size Matters: Regulating 
Nanotechnology, 31 HARV. ENVTL. L. REV. 349, 391–407 (2007) (proposing a new law 
requiring that manufacturers of certain nanotechnologies post environmental bonds). 
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and second, because passing a law to regulate nanotechnology alone might leave the 
EPA unable to regulate future technologies. 
A. The Trouble with Defining Nanotechnology 
Nanotechnology has proven difficult to define for regulatory purposes.41 As 
discussed, the EPA’s definition of nanotechnology is so broad that it fails to 
communicate a concrete definition of what nanotechnology is.42
Commentators have advanced many definitions of nanotechnology.
 In addition, it contains 
ambiguities. For example, are naturally occurring structures, such as pollen or the 
scales on butterfly wings considered nanotechnology? What about nanosized structures 
that are covered by another scientific discipline, such as peptides (biotechnology) or 
tiny transistors (computer science)? 
43 But these 
definitions are all problematic because they are either too narrow to cover the full 
range of what is considered nanotechnology or too broad to concretely convey what 
nanotechnology is.44
 However, defining the precise bounds of “nanotechnology” would not be necessary 
if nanotechnology regulation was incorporated into a broader toxic substances statute, 
such as TSCA. Part V of this Article argues that Congress should amend TSCA to 
allow the EPA to regulate all novel materials as unique substances, without requiring 
the EPA to make the finding that the materials are a form of nanotechnology. As a 
result, this approach completely avoids the thorny issue of defining nanotechnology.  
 No one yet has defined nanotechnology in a way that is both 
broad and specific. 
B. Limiting a Statute Only to Nanotechnology Would Fail to Protect Society 
Against Future Technologies 
Passing environmental reform is a politically expensive proposition. Congress has 
not passed a significant new environmental law since the environmental decade from 
1970 to 1980.45
                                                                                                                 
 
 41. See DAVIES, supra note 40, at 8 (“The answer to the definitional question—whether 
regulators and those regulated will be able to make a clear demarcation between what is and 
what isn’t considered [nanotechnology]—will depend on the details of the definition and the 
technical capability for applying it.”). 
 Thus, to adequately protect the public, Congress should pass toxic 
substances reform that is flexible enough to regulate future technologies. A 
 42. See supra Part I. 
 43. See supra note 9. 
 44. For example, Scott Segal defines nanotechnology as machines that are less than 100 
nanometers in size. Segal, supra note 9, at 291. This definition is too narrow because it ignores 
currently existing nanotechnology applications such as nanocomposites as well as potential 
future nanotechnologies such as molecule-by-molecule assemblers. See supra Part I. By 
contrast, other commentators describe nanotechnology as a “heterogeneous family of 
technologies” without further elaboration. Bowman & Hodge, supra note 9, at 2. Such a 
definition does not convey any definite idea of what nanotechnology is. 
 45. See John S. Applegate, The Taming of the Precautionary Principle, 27 WM. & MARY 
ENVTL. L. & POL’Y REV. 13, 72 (2002). 
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nanotechnology-specific law would not provide protection against future regulatory 
gaps.  
For example, imagine that scientists develop an economically promising but 
dangerous technology called “xenotechnology.” Scientists agree that xenotechnology is 
not nanotechnology, but it has characteristics that make it difficult to regulate under 
existing toxic substances law. In this case, a nanotechnology-specific law would not be 
adequate to protect society from xenotechnology. Part V of this Article proposes 
reforms to general toxic substances law that are adequate to deal with future 
technologies. 
IV. FROM TSCA TO REACH AND BACK AGAIN: RECENT DEVELOPMENTS IN TOXIC 
SUBSTANCES LAW 
This Part provides background on current toxic substances law. In particular, it 
describes the complicated relationship between TSCA and the European Union 
directive known as REACH. 
A. TSCA and Its Discontents 
TSCA is the most important toxic substances law in the United States because it 
regulates chemicals at the point of manufacture.46 The core of TSCA is its section 5 
requirement that manufacturers of a chemical substance submit a pre-manufacture 
notice (PMN) to the EPA ninety days before producing a “new chemical substance.”47 
If the EPA objects to the manufacture of the substance, section 6 of TSCA gives the 
EPA the power to issue a rule preventing or limiting the manufacture.48 TSCA also 
gives the EPA the power to limit the distribution or use of a chemical substance at any 
point in the chain of commerce, require the use of warnings on the packaging of the 
chemical substance,49 or require manufacturers of a new or existing chemical to 
perform testing to generate health or environmental data.50
Nonetheless, TSCA has been an underachiever among U.S. environmental laws. 
TSCA requires the EPA to expend considerable resources before it can take any 
regulatory action. For example, to place restrictions on a chemical under section 6, the 
burden is on the EPA to demonstrate that a chemical is an “unreasonable risk.”
 In summary, TSCA would 
seem to grant the EPA far-reaching powers to regulate chemical substances. 
51 
Federal courts have interpreted the unreasonable risk standard to require the agency to 
perform a wide-ranging cost-benefit analysis before regulating even the most 
dangerous chemicals.52
                                                                                                                 
 
 46. See 15 U.S.C. § 2604 (2006) (requiring notice prior to manufacture). By comparison, 
media-based statutes, such as the Clean Water Act and Clean Air Act, and use-based statutes, 
such as the Federal Insecticide, Fungicide, and Rodenticide Act are much narrower in scope. 
DAVIES, supra note 40, at 14–15. 
 In fact, the EPA has used its section 6 authority only four times 
 47. 15 U.S.C. § 2604(a). 
 48. 15 U.S.C. § 2605(a) (2006). 
 49. Id. § 2605(a)(2)–(3). 
 50. 15 U.S.C. § 2603 (2006). 
 51. 15 U.S.C. § 2605(a). 
 52. See, e.g., Corrosion Proof Fittings v. EPA, 947 F.2d 1201, 1223 (5th Cir. 1991). 
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to limit the use of chemicals and has never successfully used its section 6 authority to 
ban the manufacture of a chemical.53
For example, consider the EPA’s efforts to regulate asbestos. The history of 
asbestos regulation has special relevance to current efforts to regulate nanotechnology. 
In fact, if it were developed today, asbestos likely would be considered nanotechnology 
because asbestos consists of nanoscale ceramic fibers.
 
54 And like modern 
nanotechnology applications, asbestos was the “miracle material” of its day. In the 
mid-twentieth century, asbestos was prized for its fire-resistance and was widely used 
in applications including insulation, brake pads, and fire blankets.55 By the 1960s, 
strong evidence existed that corocidolite asbestos was a potent carcinogen.56 Today, 
the World Health Organization estimates that currently, 125 million individuals are 
occupationally exposed to asbestos.57
The EPA studied the health effects of asbestos for ten years, conducted over one 
hundred human health studies, and issued a TSCA section 6 rule banning the use of 
asbestos.
  
58 Despite the EPA’s exhaustive investigation, the Fifth Circuit struck down 
most of the EPA’s rule because the court determined that the EPA had not 
demonstrated that asbestos causes an “unreasonable risk.”59 The court found that the 
EPA failed to consider regulatory alternatives to a total ban, failed to consider the 
toxicity of products that would be used to replace asbestos, and failed to follow 
TSCA’s procedural provisions.60
In addition, TSCA is ineffective at gathering information about the chemicals it 
regulates. The EPA must meet the burden of demonstrating that a chemical “may 
present an unreasonable risk” before it can order testing.
  
61 This puts the EPA in a 
catch-22: the agency is required to produce information it does not have to learn what 
it does not know. A 1984 study found that no toxicity data was available for more than 
eighty percent of toxic chemicals in commerce and that toxicity data were available for 
only twenty-two percent of high volume chemicals.62
The EPA has relied on voluntary programs because of the high evidentiary standard 
imposed by TSCA. In 2008, the EPA launched the Nanotechnology Materials 
Stewardship Program to learn about the types of nanoscale materials under 
development, develop risk management practices, encourage the development of health 
and environmental test data, and encourage the responsible development of 
 
                                                                                                                 
 
 53. LYNN L. BERGESON, TSCA: TOXIC SUBSTANCES CONTROL ACT 48–49 (2000).  
 54. Brunner et al., supra note 36, at 4379–80. For this reason, asbestos fibers are often used 
as a positive control in in vitro nanotoxicology studies. See, e.g., id. 
 55. EPA, Asbestos: Basic Information, http://www.epa.gov/asbestos/pubs/help.html. 
 56. P.W.J. Bartrip, History of Asbestos Related Disease, 80 POSTGRADUATE MED. J. 72, 72 
(2004), available at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1742940. 
 57. WORLD HEALTH ORG., ELIMINATION OF ASBESTOS-RELATED DISEASES 1 (2006), 
http://www.who.int/occupational_health/publications/asbestosrelateddiseases.pdf. 
 58. John S. Applegate, Bridging the Data Gap: Balancing the Supply and Demand for 
Chemical Information, 86 TEX. L. REV. 1365, 1386 (2008). 
 59. Corrosion Proof Fittings v. EPA, 947 F.2d 1201, 1222–23 (5th Cir. 1991). 
 60. Id. at 1214–30. 
 61. 15 U.S.C. § 2603(a)(1)(A)(i) (2006). 
 62. John S. Applegate, Synthesizing TSCA and REACH: Practical Principles for Chemical 
Regulation Reform, 35 ECOLOGY L.Q. 721, 734–36 (2008). 
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nanotechnologies.63 Unfortunately, companies have been selective in reporting 
information to the program. The program’s 2009 Interim Report states that the EPA 
has received very little health and safety data about nanomaterials.64
B. REACH as a Reaction to TSCA 
 This failure 
suggests that voluntary programs alone will be inadequate to address the threats posed 
by nanotechnology. 
In 2006, the European Union enacted the directive known as REACH, which 
provides a comprehensive framework for the regulation of chemicals throughout 
Europe.65 REACH was written as a response to the regulatory paralysis created by 
TSCA,66 as well as more uniquely European concerns, such as reducing animal testing 
and harmonizing European toxic substances law.67
REACH explicitly incorporates the precautionary principle.
  
68 Fundamentally, a 
“precautionary approach” to regulation requires that technologies with an uncertain 
impact on human health or the environment be restricted until the uncertainty is 
resolved.69 It reflects the normative belief that protection of human health and 
environmental concerns trump concerns about economic efficiency.70 It also reflects 
the factual assumption that “new technologies will create novel, severe, and 
irreversible . . . harms to human health and the environment” unless preventive 
measures are taken.71
REACH’s data gathering provisions reflect this precautionary approach. REACH 
places the burden of producing health and environmental data on prospective chemical 
manufacturers.
 
72 Prospective manufacturers must submit dossiers of health and 
environmental data for any chemical to be manufactured in an amount greater than ten 
metric tons.73
                                                                                                                 
 
 63. U.S. ENVTL. PROT. AGENCY, CONCEPT PAPER FOR THE NANOSCALE MATERIALS 
STEWARDSHIP PROGRAM UNDER TSCA 1–2 (2008), available at http://www.epa.gov/opptintr/ 
nano/nmsp-conceptpaper.pdf. 
 Recent EU policy guidance makes clear that the report must include 
information on all known uses of the chemical, including the conversion of the 
 64. See U.S. ENVTL. PROT. AGENCY, NANOSCALE MATERIALS STEWARDSHIP PROGRAM 
INTERIM REPORT 9 (2009), available at http://www.epa.gov/oppt/nano/nmsp-interim-report-
final.pdf [hereinafter INTERIM REPORT]. 
 65. Applegate, supra note 62, at 723. 
 66. Id. (“[T]he Commission’s White Paper can be read as an extended critique of TSCA, 
and REACH as the legislative product of that critique.”). 
 67. Id. at 741. 
 68. Council Regulation No. 1907/2006, supra note 7, art. 1, para. 3. (“This Regulation is 
based on the principle that it is for manufacturers, importers and downstream users to ensure 
that they manufacture, place on the market or use such substances that do not adversely affect 
human health or the environment. Its provisions are underpinned by the precautionary 
principle.”).  
 69. Applegate, supra note 45, at 13. 
 70. Id. 
 71. Id. 
 72. Applegate, supra note 62, at 743.  
 73. Council Regulation No. 1907/2006, supra note 7, art. 10. 
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chemical into nanomaterials.74
REACH’s provisions for the authorization of chemical manufacture also reflect the 
precautionary principle. The precautionary approach is strongest in the case of 
chemicals that are designated to be of Very High Concern (VHC) because of 
carcinogenic, mutagenic, or bioaccumulative properties.
 Thus, REACH is expected to generate a large amount of 
health and environmental data about chemicals. 
75 In the case of VHC 
chemicals, the manufacturer must receive express permission to begin or continue 
production.76 To receive this permission, the manufacturer must demonstrate that no 
safer chemical exists and present a research plan to find alternatives.77 Furthermore, if 
the release of the chemical into the environment cannot be “adequately controlled” the 
manufacturer must demonstrate that the benefits of producing the chemical outweigh 
the costs.78
In the case of non-VHC chemicals, REACH takes a somewhat less precautionary 
approach. Article 69 states that a chemical will be restricted if the “dossier 
demonstrates that action on a Community-wide basis is necessary.”
 
79 Thus, the text of 
REACH does not clearly allocate the burden of proving safety between the agency and 
the manufacturer. However, the procedure for restricting a chemical is very 
complicated, and compliance places a substantial burden on the agency.80
C. The Movement for REACH-Based Reforms to TSCA 
 
TSCA reform, based on REACH, is a realistic prospect in near future. In February 
2009, the House Subcommittee on Commerce Trade and Consumer Protection held a 
hearing entitled “Revisiting the Toxic Substances Control Act of 1976.”81 The 
subcommittee discussed TSCA’s well-known problems, including the “unreasonable 
risk” standard for chemical regulation, its ineffectiveness at collecting information, and 
its procedural complexity.82 Regulatory reform based on REACH was discussed as a 
way to correct these shortcomings.83
                                                                                                                 
 
 74. EUROPEAN COMM’N, FOLLOW-UP TO THE 6TH MEETING OF THE REACH COMPETENT 
AUTHORITIES FOR THE IMPLEMENTATION OF REGULATION (EC) 1907/2006 (REACH) 6 (2008), 
available at http://ec.europa.eu/environment/chemicals/reach/pdf/nanomaterials.pdf. 
 Part V of this Article discusses the implications of 
REACH-based reform for nanotechnology regulation. 
 75. See Applegate, supra note 62, at 742–73 (citing Council Regulation No. 1907/2006, 
supra note 7, arts. 55–66). 
 76. Id. 
 77. Id. 
 78. Council Regulation No. 1907/2006, supra note 7, at art. 60, paras. 2, 4; see also 
Applegate, supra note 62, at 742–73. 
 79. Council Regulation No. 1907/2006, supra note 7, at art. 69 para. 3. 
 80. Applegate, supra note 58, at 746–47. 
 81. Revisiting the Toxic Substances Control Act of 1976: Hearing Before the H. Subcomm. 
on Commerce, Trade, and Consumer Protection of the H. Comm. on Energy and Commerce, 
111th Cong. (2009), available at http://energycommerce.house.gov/index.php?option= 
com_content&task=view&id=1505&Itemid=95. 
 82. Id. (statement of John Stephenson, U.S. Gov’t Accountability Office), available at 
http://energycommerce.house.gov/Press_111/20090226/testimony_gao.pdf. 
 83. See, e.g., id. at 4. 
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V. REGULATION OF NANOTECHNOLOGY: IMPLICATIONS OF REACH-BASED REFORM 
TO TSCA 
This Part discusses both the strengths and weaknesses of REACH-based reform to 
TSCA and discusses ways in which a third-generation toxic substances statute could be 
written to meet the health and environmental challenges posed by nanotechnology. 
A. Strengths of REACH-Based Reform to TSCA 
1. REACH’s Precautionary Approach Is Appropriate for Nanotechnology 
 
Preliminary research into the health and environmental effects of nanotechnology 
supports the precautionary principle’s factual assumptions that new technologies create 
novel, severe, and irreversible harms. The physical and chemical properties of 
nanotechnology are novel because they are different than the properties of existing 
materials with the same chemical composition.84 The high-surface area and resulting 
high chemical reactivity of nanomaterials leads to severe health and environmental 
consequences.85 Finally, the tendency of nanomaterials to bioaccumulate throughout 
the body (and the possibility of uncontrolled self-replicating nanotechnologies) 
supports the conclusion that nanotechnology contamination is irreversible.86
Furthermore, society’s experience with asbestos should be taken into account 
because, as discussed, asbestos shares characteristics with nanotechnology.
  
87
2. REACH’s Mandatory Information Gathering Provisions are Appropriate for 
Nanotechnology 
 Asbestos 
has characteristics that are both “magical” and dangerous. During the first half of the 
twentieth century, industry moved full-speed ahead because of the potential for 
economic gain, but, by the later half of the twentieth century, society learned that the 
use of asbestos resulted in a net loss. Thus, society’s experience with asbestos suggests 
that the precautionary approach taken by REACH is appropriate for nanotechnology.  
Very little is known about the health and environmental risks of most 
nanotechnology applications for at least two reasons. First, the EPA has only limited 
information about the types of nanotechnologies under development by private 
industry. At the present time, EPA knowledge is limited to the voluntary submissions 
of sixteen companies under the auspices of the Nanotechnology Stewardship 
Program.88 Second, the EPA has very limited health and safety information regarding 
known nanotechnology applications. Even companies participating in the Stewardship 
Program have not provided the EPA health and environmental data.89
                                                                                                                 
 
 84. See supra Part II. 
 
 85. See supra Part II. 
 86. See supra Part II. 
 87. See supra Part IV.A. 
 88. INTERIM REPORT, supra note 64, at 9. 
 89. Id. at 11.  
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TSCA is inadequate to close these data gaps for at least two reasons. First, TSCA’s 
PMN requirement applies only to “new” and not “existing” chemicals.90 The EPA 
treats a chemical as existing if it is listed on TSCA’s Chemical Substance Inventory.91 
As a result, nanotechnology versions of chemicals that are already listed on the 
Inventory are not subject to the PMN requirement.92 Thus, the EPA is not informed 
when a novel nanotechnology application is manufactured if it is manufactured from an 
existing chemical. Second, even if the EPA was informed about the existence of a 
novel nanotechnology application, it would be unable to require health and 
environmental testing because of TSCA’s demanding evidentiary requirements.93
REACH provides much better tools to close the nanotechnology data gap. As 
discussed, REACH requires prospective manufacturers to submit dossiers disclosing 
any nanotechnology uses of manufactured chemicals.
 
94 Furthermore, manufacturers 
must produce health and safety data regarding those uses.95
3. TSCA Provides Flexibility in Regulating Chemicals 
 Thus, REACH-based 
reform of United States toxic substances law would result in the generation of much-
needed health and environmental data regarding nanotechnology. 
As discussed in Part I, nanotechnology is extremely heterogeneous. Future 
applications of nanotechnology will be as diverse as processes for the molecule-by-
molecule assembly of large-scale consumer goods (such as vehicles),96 implants that 
will allow the human brain to interface with external technology,97 and tiny machines 
that will be able to remediate toxic waste sites.98
TSCA’s strength is its flexibility. As discussed, TSCA provides the EPA with a 
wide selection of actions to restrict chemicals at any point in the chain of commerce.
 This diversity suggests that the EPA 
should have the authority to assess nanotechnology applications on a case-by-case 
basis and take whatever action is appropriate to protect the public. 
99 
(Of course, EPA’s power to take these actions is undercut by TSCA’s lack of 
precaution, which is a separate issue.)100
                                                                                                                 
 
 90. U.S. ENVTL. PROT. AGENCY, TSCA INVENTORY STATUS OF CHEMICAL SUBSTANCES—
GENERAL APPROACH 1–2 (2008), available at http://www.epa.gov/oppt/nano/nmsp-
inventorypaper2008.pdf [hereinafter General Approach]. 
 A third-generation toxic substances statute 
should maintain TSCA’s flexibility of response to effectively regulate diverse forms of 
nanotechnology. 
 91. Id. 
 92. Id. 
 93. See supra Part IV.A. 
 94. See supra Part IV.B. 
 95. See supra Part IV.B. 
 96. See Reynolds, supra note 9, at 181. 
 97. See Statement of Kurzweil, supra note 4, at 34–36. 
 98. Pratim Biswas & Chang-Yu Wu, Nanoparticles and the Environment, 55 J. AIR & 
WASTE MGMT. ASS’N 708, 710 (2005). 
 99. See supra Part IV.A. 
 100. See supra Part IV.A. 
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B. Problems with REACH-Based reform of TSCA 
1. Definition of Subject Matter 
 
Both TSCA and REACH define their subject matter in a way that would make it 
difficult to regulate nanotechnology. TSCA defines “chemical substances” to mean 
“any organic or inorganic substance of a particular molecular identity . . . .”101 The 
EPA interprets “molecular identity” to mean “the types and number of chemical bonds, 
the connectivity of the atoms in the molecule, and the spatial arrangement of the atoms 
within the molecule.”102 In other words, under TSCA, “chemical substances” are 
defined in terms of “molecules,” which are arrangements of atoms. Unfortunately, 
nanotechnology applications are often defined by arrangements of molecules—that is, 
arrangements at a higher structural level than the definition of chemical substances in 
TSCA can capture.103
As a result, many nanomaterials are not recognized as “new chemical substances” 
subject to PMN reporting. For example, consider nanoscale titanium dioxide. Titanium 
dioxide is an “existing” chemical for purposes of TSCA.
 
104 Therefore, a producer of 
nanoscale titanium dioxide is not required to give premanufacture notice. This is true 
even though nanoscale titanium dioxide is used in sunscreens precisely because of its 
novel physical and chemical properties.105
In a handful of cases, the EPA has stretched the meaning of “chemical substances” 
to include structures that, like nanotechnology, are organized above the atomic level. 
For example, the EPA has asserted that the definition of chemical substances is broad 
enough to cover microorganisms, which can hardly be described as molecules.
  
106 This 
broad approach is also found in EPA’s definition of Class 2 chemical substances, 
which are defined as having a chemical composition that “cannot be fully represented 
by a complete, specific chemical structure diagram.”107
However, these designations have not been challenged in court. If they were, they 
might be struck down. Courts typically review agency definitions of terms in statutes 
with Chevron
 
108 deference.109 Under Chevron deference, the reviewing court will 
typically uphold the agency’s interpretation unless it is counter-textual.110
                                                                                                                 
 
 101. 15 U.S.C. § 2602(2)(A) (2006) (emphasis added). 
 However, in 
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 103. See id. at 4. 
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particular molecular identity,”111
Unfortunately, the definition of “substance” in REACH also lacks the scope to 
regulate most nanotechnology. “Substance” is defined to mean:  
 is clearly a problem in the context of novel substances 
that are defined by more than the connectivity of their atoms. 
a chemical element and its compounds in a natural state or obtained by any 
manufacturing process, including any additive necessary to preserve its stability 
and any impurity deriving from the process used, but excluding any solvent which 
may be separated without affecting the stability of the substance or changing its 
composition.112
A recent EU policy document is cryptic about whether this definition is sufficient to 
distinguish nanotechnology from ordinary materials.
  
113
Thus, neither TSCA nor REACH contains a definition of subject matter that is 
adequate to regulate nanotechnology. The definition of subject matter in a third-
generation toxic substances statute should avoid limiting language such as “of a 
particular molecular identity” or “a chemical element and its compounds.” A suggested 
definition for “substances” would be: any state of matter, combined or uncombined, as 
distinguished by any physical or chemical property, or any process for the production 
of such a state of matter. 
  
2. Chemical Safety Reports Should Not Be Limited to High Volume Chemicals 
As discussed in Part II, nanotechnology applications can be much more toxic per 
unit mass than ordinary chemicals. Thus, the assumption that low volumes of chemicals 
are not dangerous is not valid for nanotechnology. Unfortunately, both REACH and 
TSCA incorporate this assumption.  
REACH contains an exemption for chemicals that are manufactured in amounts less 
than ten metric tons per year.114 The EPA has also implemented a Low Volume 
Exemption under TSCA, which exempts manufacturers who produce less than 10 
metric tons of chemical per year from PMN requirements.115
 
 A third-generation toxic 
substances statute should avoid incorporating the assumption that low volumes of 
chemicals will have a de minimus environmental impact.  
 CONCLUSION 
For many years reformers from the academic, regulatory, and environmental 
communities have been drawing up plans to improve or replace TSCA. In many ways, 
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the enactment of REACH was a victory for these reformers. Understandably, they want 
to seize the momentum and make similar changes to toxic chemicals regulation in the 
United States. 
But nanotechnology is a game-changer. Nanotechnology challenges the very 
definition of what chemicals are. Furthermore, many of the ideas that reformers have 
developed in the decades after the enactment of TSCA do not adequately take account 
of nanotechnology. As a result, proposed reforms need to be reevaluated. If this is 
done, the result will be a third-generation toxic substances statute that both overcomes 
TSCA’s legacy of failure and looks forward to the technological future.  
 
 
 
